Showing results (851-860 of 1,120) with videos related to

Sort By:
Pageof 112
The Lancet. Diabetes & Endocrinology|July 6, 2019
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trialKausik K Ray, Helen M Colhoun, Michael Szarek, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 13, 2013
Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and designLuciano A Sposato, Mariano L Coppola, Juan Altamirano, et al.
Circulation|December 3, 2020
Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment ComparisonsBernard R Chaitman, Karen P Alexander, Derek D Cyr, et al.
JAMA Cardiology|April 4, 2019
Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical TrialM Julia Machline-Carrion, Rafael Marques Soares, Lucas Petri Damiani, et al.
NEJM Evidence|February 6, 2024
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic ValveTracy Y Wang, Lars G Svensson, Jun Wen, et al.
American Heart Journal|October 24, 2022
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and designAdam J Nelson, Neha J Pagidipati, Michelle D Kelsey, et al.
American Heart Journal|November 15, 2019
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trialsJ Matthew Brennan, Lisa Wruck, Michael J Pencina, et al.
JAMA Cardiology|June 1, 2022
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A ReviewBehnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, et al.
Circulation|December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 TrialsAlexander C Fanaroff, Robert Clare, Karen S Pieper, et al.
American Heart Journal|June 17, 2018
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trialOtavio Berwanger, Jose C Nicolau, Antonio C Carvalho, et al.
Pageof 112